Skip to main content
Log in

Enhanced PON1 activity in the kidneys of cyclophosphamide treated rats may play a protective role as an antioxidant against cyclophosphamide induced oxidative stress

  • Molecular Toxicology
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

Recent studies have shown that paraoxanase (PON1) has protective effect against oxidative stress and hence can act as an antioxidant. A time course study was carried out in order to find out alterations in PON1 activity in cyclophosphamide (CYP) induced renal injury. Eight to ten weeks old female rats were administered CYP at the dose of 150 mg/kg body wt. (i.p.) and sacrificed at 6, 16, or 24 h after treatment. Saline treated rats served as control. CYP exposure for 6 h caused a dramatic increase in PON1 activity (83%), which escalated to 160% at 16 h. The renal PON1 activity reached control values 24 h after treatment with CYP. The renal malondialdehyde level was unaltered 6 h after treatment with CYP and an increase by 35% was observed 16 h after treatment with CYP. The present investigation shows for the first time that an increase in renal PON1 activity is an early biochemical event in cyclophosphamide induced renal damage. It is suggested that this enzyme may have a role within the antioxidant systems of the kidney.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Costa LG, Richter RJ, Li WF, Cole T, Guizzetti M, Furlong CE (2003) Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity. Biomarkers 8:1–12 Review

    Article  PubMed  CAS  Google Scholar 

  • Costa LG, Cole TB, Furlong CE (2005) Paraoxonase (PON1): from toxicology to cardiovascular medicine. Acta Biomed 76(Suppl 2):50–57

    PubMed  Google Scholar 

  • Dollery C (1999) Cyclophosphamide. In: Dollery C (ed) Therapeutic drugs. Churchill Livingstone, Edinburgh, pp 349–353

    Google Scholar 

  • Ellman GL (1959) Tissue sulphydryl groups. Arch Biochem Biophys 82:70–77

    Article  PubMed  CAS  Google Scholar 

  • Gur M, Aslan M, Yildiz A, Demirbag R, Yilmaz R, Selek S, Erel O, Ozdogru I (2006) Paraoxonase and aryl esterase activities in coronary artery disease. Eur J Clin Invest 36:779–787

    Article  PubMed  CAS  Google Scholar 

  • Manda K, Bhatia AL (2003) Prophylatic action of melatonin against cyclophosphamide induced oxidative stress in mice. Cell Biol Toxicol 19:367–372

    Article  PubMed  CAS  Google Scholar 

  • Ohkawa H, Oshini N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric reaction. Anal Biochem 95:351–358

    Article  PubMed  CAS  Google Scholar 

  • Takahashi Y, Aoyama F, Ito F, YamamuraY (1967) Evaluation of phenyl acetate esterase activity as an index of liver damage. Clin Chim Acta 18:21–32

    Article  PubMed  CAS  Google Scholar 

  • Tsuzura S, Ikeda Y, Suehiro T, Ota K, Osaki F, Arii K, Kumon Y, Hashimoto K (2004) Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes. Metabolism 53:297–302

    Article  PubMed  CAS  Google Scholar 

  • Vasdev S, Gill V, Singal PK (2006) Beneficial effect of low ethanol intake on the cardiovascular system: possible biochemical mechanisms. Vasc Health Risk Manag 2:263–276

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank CMC research committee for the financial support for the study and Dr Indirani, Associate professor in Anatomy for her guidance in histological studies

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Premila Abraham.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abraham, P., Sugumar, E. Enhanced PON1 activity in the kidneys of cyclophosphamide treated rats may play a protective role as an antioxidant against cyclophosphamide induced oxidative stress. Arch Toxicol 82, 237–238 (2008). https://doi.org/10.1007/s00204-007-0240-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-007-0240-3

Keywords

Navigation